Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

HYDROXYUREA DIN 02343096

Status: Cancelled Post Market
Holder: SANIS HEALTH INC
Molecule: HYDROXYUREA

Health Canada record

Active ingredient(s)HYDROXYUREA 500 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01XX05 HYDROXYCARBAMIDE
Original market date25-Feb-2010
Current status date31-Jul-2017
SourceHealth Canada DPD

Establishment licence of the holder

Sanis Health Inc. — licence 101796, currently licensed, last inspection rating I (2024-07-23).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing HYDROXYUREA

DINProductCompanyFormStrengthStatus
02247937APO-HYDROXYUREAAPOTEX INCCapsuleHYDROXYUREA 500 MGMarketed
02552582EUGIA-HYDROXYUREAEUGIA PHARMA INC.CapsuleHYDROXYUREA 500 MGApproved
00465283HYDREACHEPLAPHARM ARZNEIMITTEL GMBHCapsuleHYDROXYUREA 500 MGMarketed
02242920MYLAN-HYDROXYUREAMYLAN PHARMACEUTICALS ULCCapsuleHYDROXYUREA 500 MGMarketed
02530260RIVA-HYDROXYUREALABORATOIRE RIVA INC.CapsuleHYDROXYUREA 500 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
110232010-02-08Abbreviated New Drug Submission (ANDS)New manufacturer and product name

International API supply for HYDROXYUREA

4 active FDA Drug Master Files.

Request a quote for HYDROXYUREA

How to read a Canadian DIN record